News

A newly-developed computational framework for drug discovery has been used to identify a therapeutic target for epilepsy.

Grouping four or five existing medications could help slow antibiotic-resistant bacteria.

Scientists have developed a way to see brain cells talk – to actually see neurons communicate in bright, vivid color. The new lab technique is set to provide long-needed answers about the brain and neurological diseases such as Alzheimer’s disease, schizophrenia and depression.

The results of the study could help reduce malaria-associated mortality.

Results from a clinical trial of more than 250 participants with progressive multiple sclerosis (MS) revealed that ibudilast was better than a placebo in slowing down brain shrinkage.

Emerging concepts may contribute to a multidisciplinary approach for diagnosis, risk prediction and treatment of NAFLD.

Researchers have modified the protein Nurr1 so that it can enter cells from the outside. Nurr1 deficiency may be one of the causes of Parkinson's disease. Even though Nurr1 has potential to be a target for the treatment of Parkinson's disease, it is unusable in its normal form, as it cannot penetrate cells. A team have now deployed a bacterial import signal in order to deliver Nurr1 into cells.

A translational research team led by the National University of Singapore (NUS) has harnessed CURATE.AI, a powerful artificial intelligence (AI) platform, to successfully treat a patient with advanced cancer, completely halting disease progression.

“Most importantly we found the drug to be active in cells from people with the most common type of sporadic Alzheimer’s disease."

Researchers used autonomous underwater robots and a remotely operated vehicle, to acquire 1.3 million high resolution images of the seafloor at Hydrate Ridge, composing them into the largest known high resolution color 3D model of the seafloor.